Technology
Health
Biotechnology

Precipio

$3.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.31%) Today
+$0.02 (0.66%) As of 4:03 PM EDT after-hours

Why Robinhood?

You can buy or sell Precipio and other stocks, options, ETFs, and crypto commission-free!

About PRPO

Precipio, Inc. Common Stock, also called Precipio, is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Read More Its products and services include MX-ICP and HemeScreen HRM kits, SmartPath, SmartGen, and ICP liquid biopsy testing. The company was founded in March 1997 and is headquartered in New Haven, CT.

Employees
45
Headquarters
New Haven, Connecticut
Founded
1997
Market Cap
13.17M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.64M
High Today
$3.13
Low Today
$2.90
Open Price
$3.08
Volume
189.95K
52 Week High
$10.80
52 Week Low
$0.1101

Collections

Technology
Health
Biotechnology
Cancer Prevention
2014 IPO
US
North America

PRPO Earnings

-$1.01
-$0.73
-$0.45
-$0.17
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.37 per share
Actual
Expected Aug 14, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.